With a New Identity, Travere Thearpeutics Seeks to Find Its True Path
RARECast - En podkast av RARECast - Torsdager
Kategorier:
Eric Dube, CEO of Travere Therapeutics, discusses the company’s new identity, its experimental therapy sparsentan, and the rare kidney diseases it is being developed to treat.
